The Effect of Niacinamide Supplementation on Phosphate Concentrations in Dutch Dialysis Patients: A Randomized Crossover Trial
Journal of Renal Nutrition · 2024
DOI: 10.1053/j.jrn.2024.02.005 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Renal Nutrition, 2024. Verfasst von Lara Schepers und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands. Hauptthemen laut MEDLINE: Cross-Over Studies, Renal Dialysis, Phosphates, Hyperphosphatemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVE: Hyperphosphatemia is a common complication in patients with kidney failure, despite the use of phosphate binders. Vitamin B3, either in the form of niacin or niacinamide (NAM), shows potential as "add-on" treatment to reduce serum phosphate concentrations in this population. NAM seems to lack many of the side effects that are observed with niacin. The aim of this study was to investigate whether NAM is an effective and acceptable treatment in reducing serum phosphate concentrations in patients with kidney failure. METHODS: DiaNia was a double-blind placebo-controlled randomized crossover trial, comparing NAM (250-500 mg/day) to placebo as "add-on" treatment to an individual treatment with approved phosphate binders for 12 weeks in patients receiving hemodialysis. The primary outcome was serum phosphate concentrations, and the secondary outcomes were platelet counts as well as drop-outs due to side effects. Data were analyzed using both per-protocol and intention-to-treat analyses. RESULTS: Mean age of the per-protocol population (n = 26) was 63.6 ± 17.2 years and 53.8% were men. NAM treatment significantly reduced serum phosphate with 0.59 mg/dL (p = .03). Linear mixed-effects models demonstrated superiority of 12 weeks NAM over 12 weeks placebo with a between-treatment difference of 0.77 mg/dL (95% CI 0.010, 1.43; P = .03). Similar results, although not significant, were found in the intention-to-treat population. We found no between-treatment differences in platelet counts and during the NAM treatment we observed 3 drop-outs due to side effects (8.6%). CONCLUSION: NAM is effective in reducing serum phosphate concentrations in patients with kidney failure receiving hemodialysis. In addition, NAM is well-tolerated and seems not to increase the risk of thrombocytopenia. Thus, NAM can be valuable as "add-on" treatment to combat hyperphosphatemia in patients with kidney failure. However, more research in larger populations is needed to confirm this.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.
- Department of Nutrition and Dietetics, Hospital Gelderse Vallei, Ede, the Netherlands, Nutrition & Healthcare Alliance, Ede, The Netherlands.
- Nutrition & Healthcare Alliance, Ede, The Netherlands.
- Department of Nephrology, Hospital Gelderse Vallei, Ede, The Netherlands.
- Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands. Electronic address: nicole.deroos@wur.nl.
Zitieren
APA
Schepers, L., Jans, I., Pot, G. K., Smilde, A. J., Hofstra, J. M., & de Roos, N. M. (2024). The Effect of Niacinamide Supplementation on Phosphate Concentrations in Dutch Dialysis Patients: A Randomized Crossover Trial. Journal of Renal Nutrition. https://doi.org/10.1053/j.jrn.2024.02.005
Vancouver
Schepers L, Jans I, Pot GK, Smilde AJ, Hofstra JM, de Roos NM. The Effect of Niacinamide Supplementation on Phosphate Concentrations in Dutch Dialysis Patients: A Randomized Crossover Trial. Journal of Renal Nutrition. 2024. doi:10.1053/j.jrn.2024.02.005
BibTeX
@article{Schepers2024,
author = {Schepers, Lara and Jans, Inez and Pot, Gerda K and Smilde, Arend-Jan and Hofstra, Julia M and de Roos, Nicole M},
title = {The Effect of Niacinamide Supplementation on Phosphate Concentrations in Dutch Dialysis Patients: A Randomized Crossover Trial},
journal = {Journal of Renal Nutrition},
year = {2024},
doi = {10.1053/j.jrn.2024.02.005}
}
EUVIMED